Ravi Pharmascience Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2021.
2021 Mumbai, Maharashtra, India Active
Last Updated:
About Ravi Pharmascience Private Limited

Ravi Pharmascience Private Limited, a active private limited company, was established on 19 January 2021 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH2021PTC353761. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Vinod Singhania (Director), Siddharth Singhania (Director). Its latest AGM occurred on 27 September 2025, with the balance sheet filed on 31 March 2025. It is based at 121 12 Floor Plot-209, Atlanta Building Jamnalal Bajaj Marg, Nariman Point, Mumbai, Maharashtra, 400021.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MH2021PTC353761

  • Registration Number

    353761

  • Incorporation Date

    19 January 2021

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 21 Days
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** -30.05%
  • Profit Growth **** -53.37%
  • Ebitda **** -41.72%
  • Net Worth 41.99%
  • Total Assets **** 15.19%
Company report

Ravi Pharmascience Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ravi Pharmascience Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Ravi Pharmascience Private Limited?
Current Directors
Name Designation Appointment Date Status
Vinod Singhania Director 19 Jan 2021 Current
Siddharth Singhania Director 19 Jan 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ravi Pharmascience.

Ravi Pharmascience Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 30.05% decrease. The company also saw a substantial fall in profitability, with a 53.37% decrease in profit. The company's net worth Soared by an impressive increase of 41.99%.

Ravi Pharmascience revenue growth over time
Ravi Pharmascience profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
-30.05%
*******
*******
*******
*******
Revenue from Operations
*******
-30.05%
*******
*******
*******
*******
Total Assets
*******
15.19%
*******
*******
*******
*******
Profit or Loss
*******
-53.37%
*******
*******
*******
*******
Net Worth
*******
41.99%
*******
*******
*******
*******
EBITDA
*******
-41.72%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ravi Pharmascience?

In 2023, Ravi Pharmascience had a promoter holding of 2.00% and a public holding of 98.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ravi Pharmascience?

Ravi Pharmascience has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ravi Pharmascience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ravi Pharmascience's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ravi Pharmascience
Recent Activity within the Organization
  • Annual General Meeting

    The activity Ravi Pharmascience Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Ravi Pharmascience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Director Appointment

    The activity Vinod Singhania was appointed as a Director was appointed as a Director on 19 Jan 2021 & has been associated with this company since 5 years 21 days . was completed.

  • Director Appointment

    The activity Siddharth Singhania was appointed as a Director was appointed as a Director on 19 Jan 2021 & has been associated with this company since 5 years 21 days . was completed.

  • Company Incorporation

    The activity Ravi Pharmascience Private Limited was registered on 19 Jan 2021 with Roc Mumbai & aged 5 years 21 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ravi Pharmascience Private Limited?

The CIN of Ravi Pharmascience Private Limited is U24230MH2021PTC353761.

Where is Ravi Pharmascience Private Limited headquartered?

Ravi Pharmascience Private Limited is headquartered at 121 12 Floor Plot-209, Atlanta Building Jamnalal Bajaj Marg, Nariman Point, Mumbai, Maharashtra, 400021.

When was Ravi Pharmascience Private Limited incorporated?

Ravi Pharmascience Private Limited was incorporated on 19 January 2021.

Who are the current directors of Ravi Pharmascience Private Limited?

The current directors of Ravi Pharmascience Private Limited are

What is the primary industry of Ravi Pharmascience Private Limited?

The primary industry of Ravi Pharmascience Private Limited is Manufacturing.

Is Ravi Pharmascience Private Limited a listed company?

Ravi Pharmascience Private Limited is unlisted.

What is the capital structure of Ravi Pharmascience Private Limited?

The authorized capital of Ravi Pharmascience Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available